ProGRP: a new biomarker for small cell lung cancer
作者： Rafael Molina , Xavier Filella , Josep M. Augé
DOI: 10.1016/J.CLINBIOCHEM.2004.05.007
关键词:
摘要: … Our data of ProGRP serum levels in patients with malignancies other than lung cancer are shown in Table 2. Abnormal ProGRP serum levels were found in 17 of the 149 patients …
elsevier.com
sci-hub.se 参考文章(42)
R. Molina, C. Agusti, J.M. Mañe, X. Filella, J. Jo, J. Joseph, N. Giménez, J. Estapé, A.M. Ballesta, CYFRA 21-1 in lung cancer: comparison with CEA, CA 125, SCC and NSE serum levels. International Journal of Biological Markers. ,vol. 9, pp. 96- 101 ,(1994) , 10.1177/172460089400900206
Hans Lilja, Herbert A. Fritsche, Eleftherios P. Diamandis, Tumor Markers : Physiology, Pathobiology, Technology, and Clinical Applications ,(2002)
U Lassen, K Osterlind, M Hansen, P Dombernowsky, B Bergman, H H Hansen, Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patients. Journal of Clinical Oncology. ,vol. 13, pp. 1215- 1220 ,(1995) , 10.1200/JCO.1995.13.5.1215
Noboru Yanaihara, Toru Kameya, Sanae Taguchi, Isamu Adachi, Kaoru Abe, Ken Yamaguchi, Kotomi Otsubo, Production and molecular size heterogeneity of immunoreactive gastrin-releasing peptide in fetal and adult lungs and primary lung tumors. Cancer Research. ,vol. 43, pp. 3932- 3939 ,(1983)
H H Berendsen, L de Leij, S Poppema, P E Postmus, A Boes, H J Sluiter, H The, Clinical characterization of non-small-cell lung cancer tumors showing neuroendocrine differentiation features. Journal of Clinical Oncology. ,vol. 7, pp. 1614- 1620 ,(1989) , 10.1200/JCO.1989.7.11.1614
S L Graziano, R Mazid, N Newman, A Tatum, A Oler, J A Mortimer, J J Gullo, S M DiFino, A J Scalzo, The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer. Journal of Clinical Oncology. ,vol. 7, pp. 1398- 1406 ,(1989) , 10.1200/JCO.1989.7.10.1398
R Molina, X Filella, M D Torres, A M Ballesta, P Mengual, A Cases, A Balaque, SCC antigen measured in malignant and nonmalignant diseases. Clinical Chemistry. ,vol. 36, pp. 251- 254 ,(1990) , 10.1093/CLINCHEM/36.2.251
I. Maestu, M. Pastor, J. Gómez-Codina, J. Aparicio, A. Oltra, C. Herranz, J. Montalar, B. Munárriz, G. Reynés, Pretreatment prognostic factors for survival in small-cell lung cancer: a new prognostic index and validation of three known prognostic indices on 341 patients. Annals of Oncology. ,vol. 8, pp. 547- 553 ,(1997) , 10.1023/A:1008212826956
N Saijo, T Shinkai, T Kasai, Y Ohe, T Tamura, N Yamamoto, T Okusaka, K Eguchi, T Kurata, Serum levels of pro-gastrin-releasing peptide for follow-up of patients with small cell lung cancer. Clinical Cancer Research. ,vol. 3, pp. 123- 127 ,(1997)
Emilio Bombardieri, Paolo Foa, Luigi Santambrogio, Sarah Caldiera, Monica Fornier, Marco Sala, Ignazio Cataldo, Ettore Seregni, Rosalba Miceli, Mario Nosotti, Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer. Anticancer Research. ,vol. 19, pp. 3613- 3618 ,(1999)